Promising results with zongertinib in advanced-stage HER2-mutant NSCLC
Nature Reviews Clinical Oncology – Promising results with zongertinib in advanced-stage HER2-mutant NSCLC
Related Articles
Deciphering the influence of socioeconomic status on brain structure: insights from Mendelian randomization
Molecular Psychiatry – Deciphering the influence of socioeconomic status on brain structure: insights from Mendelian randomization
AI-Based screening for thoracic aortic aneurysms in routine breast MRI
Nature Communications – Routine breast MRI scans provide an opportunity to screen for thoracic aortic aneurysms, which are more fatal in women. Here, the authors…
A food-sensitive olfactory circuit drives anticipatory satiety
Nature Metabolism – The authors describe a sensory circuit involving the medial septum (MS), where MS glutamatergic neurons integrate food odours to prime satiety and…
Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC
Nature Reviews Clinical Oncology – Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC
T-DXd effective as second-line therapy in G/GEJ cancers
Nature Reviews Clinical Oncology – T-DXd effective as second-line therapy in G/GEJ cancers
Regional emperor penguin population declines exceed modelled projections
Communications Earth & Environment – The number of emperor penguins in the Bellingshausen and Weddell Sea declined by 22% over the period 2009–2023, a reduction…
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity
Nature Reviews Cancer – In this Review, Simpson et al. summarize the emergent understanding of molecular subtypes of small cell lung cancer (SCLC). They discuss…
Brain implantation of soft bioelectronics via embryonic development
Nature – A soft mesh microelectrode array can seamlessly integrate in developing brains, enabling long-term, stable mapping of how single-neuron activity and population dynamics emerge…
A new first-line standard-of-care for BRAFV600E-mutated mCRC
Nature Reviews Clinical Oncology – A new first-line standard-of-care for BRAFV600E-mutated mCRC
Neoadjuvant nivolumab plus chemotherapy improves overall survival in resectable NSCLC
Nature Reviews Clinical Oncology – Neoadjuvant nivolumab plus chemotherapy improves overall survival in resectable NSCLC